Clinical trialsRegistry-verifiedHospital-route model

GHU St Anne Psychiatrie et Neurosciences

Paris, France

Treatment & access

  • Treatments offeredPsilocybin
  • Access routeTrial
  • Cost & coverage (registry status)Free within clinical trial
  • Websitehttps://www.ghu-paris.fr

About this provider

Compiled from the registry data on this page.

GHU St Anne Psychiatrie et Neurosciences, 1 rue Cabanis, Paris, France, is listed as a clinical trial site for psilocybin. The entry is based on CTIS, the EU Clinical Trials Information System, trial 2024-512911-34-00 (PSILOTRAZ): a randomized controlled proof-of-concept study of a psilocybin and trazodone combination in treatment-resistant depression, sponsored by Groupe Hospitalier Universitaire Paris Psychiatrie & Neuroscience. Access is through trial participation, and treatment is free within the clinical trial. The CTIS public record is the registry source cited by this entry. The record was last verified on 2026-08-01.

2 more verified providers within 50 km

See them on the provider map →

Verification

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to GHU St Anne Psychiatrie et Neurosciences, with your consent.

What to prepare before you enquire

  • A referral or the contact details of your treating clinician
  • A list of medications you have tried (names, doses, duration)
  • A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.